Stock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market

Stock Track02-21

GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.

The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.

GRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1117930013?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-21 14:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117930013","market":"us","top_or_hot":-1,"title":"Stock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market","media":"Stock Track","content":"<p>GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.</p>\n\n<p>The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.</p>\n\n<p>GRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-21 14:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.</p>\n\n<p>The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.</p>\n\n<p>GRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GRAL","symbol_name":"GRAIL, Inc.","start_time":0,"source_url":"","article_id":"1117930013","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117930013","pubTimestamp":1740120751,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"GRAIL, Inc.  saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund , an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer e","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GRAL":"GRAIL, Inc."},"translate_title":"股票追踪GRAIL，Inc.股价因癌症筛查市场前景乐观而飙升11.68%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GRAL":1},"content_text":"GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.\nThe surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.\nGRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1117930013"}